Cabozantinib: A narrative drug review
2023 · Cancer Research Statistics and Treatment · 9 citations
https://doi.org/10.4103/crst.crst_9_23
A
Ajay Singh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
887
Citations
14
h-index
18
i10-index
Ajay Singh is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Intraocular Surgery and Lenses & Lung Cancer Treatments and Mutations & Retinal and Macular Surgery. The author has an h-index of 14, co-authored 84 publications.
ORCID: 0000-0003-4969-7681Papers by this author
worksClinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings
2022 · JTO Clinical and Research Reports · 6 citations
https://doi.org/10.1016/j.jtocrr.2022.100443
Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study
2023 · Cureus · 3 citations
https://doi.org/10.7759/cureus.46646
Lorlatinib in the second line and beyond for ALK positive lung cancer: real-world data from resource-constrained settings
2024 · BJC Reports · 3 citations
https://doi.org/10.1038/s44276-024-00055-9
Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspective
2025 · Discover Oncology · 3 citations
https://doi.org/10.1007/s12672-025-01864-1
Leading from the front: Real-world treatment of metastatic hormone-sensitive prostate cancer in the Northwest of England
2025 · Clinical Oncology · 2 citations
https://doi.org/10.1016/j.clon.2024.10.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat